(Q43901204)

English

Risk of acute coronary events associated with glyburide compared with gliclazide use in patients with type 2 diabetes: a nested case-control study

scientific article published on 19 July 2013

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

27 November 2017

Risk of acute coronary events associated with glyburide compared with gliclazide use in patients with type 2 diabetes: a nested case-control study (English)

1 reference

Europe PubMed Central

27 November 2017

type 2 diabetes

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

John-Michael Gamble

3

1 reference

Europe PubMed Central

27 November 2017

Jeffrey A Johnson

4

1 reference

Europe PubMed Central

27 November 2017

author name string

A S Abdelmoneim

1

1 reference

Europe PubMed Central

27 November 2017

D T Eurich

2

1 reference

Europe PubMed Central

27 November 2017

J M Seubert

5

1 reference

Europe PubMed Central

27 November 2017

W Qiu

6

1 reference

Europe PubMed Central

27 November 2017

S H Simpson

7

1 reference

Europe PubMed Central

27 November 2017

publication date

19 July 2013

1 reference

Europe PubMed Central

27 November 2017

Diabetes, Obesity and Metabolism

1 reference

Europe PubMed Central

27 November 2017

16

1 reference

Europe PubMed Central

27 November 2017

1

1 reference

Europe PubMed Central

27 November 2017

22-29

1 reference

Europe PubMed Central

27 November 2017

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

1 reference

https://api.crossref.org/works/10.1111%2FDOM.12173

21 January 2018

Risk of mortality and adverse cardiovascular outcomes in type 2 diabetes: a comparison of patients treated with sulfonylureas and metformin

1 reference

https://api.crossref.org/works/10.1111%2FDOM.12173

21 January 2018

Decreased mortality associated with the use of metformin compared with sulfonylurea monotherapy in type 2 diabetes

1 reference

https://api.crossref.org/works/10.1111%2FDOM.12173

21 January 2018

Sulfonylurea drugs increase early mortality in patients with diabetes mellitus after direct angioplasty for acute myocardial infarction.

1 reference

https://api.crossref.org/works/10.1111%2FDOM.12173

21 January 2018

Role of previous treatment with sulfonylureas in diabetic patients with acute myocardial infarction: results from a nationwide French registry

1 reference

https://api.crossref.org/works/10.1111%2FDOM.12173

21 January 2018

Adverse cardiovascular events during treatment with glyburide (glibenclamide) or gliclazide in a high-risk population

1 reference

https://api.crossref.org/works/10.1111%2FDOM.12173

21 January 2018

Sulfonylureas are not associated with increased mortality in diabetics treated with thrombolysis for acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1111%2FDOM.12173

21 January 2018

Myocardial infarction in diabetic vs non-diabetic subjects. Survival and infarct size following therapy with sulfonylureas (glibenclamide)

1 reference

https://api.crossref.org/works/10.1111%2FDOM.12173

21 January 2018

Relation between sulfonylurea therapy, complications, and outcome for elderly patients with acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1111%2FDOM.12173

21 January 2018

Variations in tissue selectivity amongst insulin secretagogues: a systematic review

1 reference

https://api.crossref.org/works/10.1111%2FDOM.12173

21 January 2018

Are sulphonylureas all the same? A cohort study on cardiovascular and cancer-related mortality

1 reference

https://api.crossref.org/works/10.1111%2FDOM.12173

21 January 2018

Electrophysiology of the pancreatic beta-cell

1 reference

https://api.crossref.org/works/10.1111%2FDOM.12173

21 January 2018

Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium

1 reference

https://api.crossref.org/works/10.1111%2FDOM.12173

21 January 2018

Preconditioning: a paradigm shift in the biology of myocardial ischemia

1 reference

https://api.crossref.org/works/10.1111%2FDOM.12173

21 January 2018

Blockade of ATP-sensitive potassium channels prevents myocardial preconditioning in dogs

1 reference

https://api.crossref.org/works/10.1111%2FDOM.12173

21 January 2018

Sulfonylureas and cardiovascular effects: from experimental data to clinical use. Available data in humans and clinical applications

1 reference

https://api.crossref.org/works/10.1111%2FDOM.12173

21 January 2018

Limitation of infarct size in the rabbit by ischaemic preconditioning is reversible with glibenclamide

1 reference

https://api.crossref.org/works/10.1111%2FDOM.12173

21 January 2018

Patterns of care and outcomes differ for urban versus rural patients with newly diagnosed heart failure, even in a universal healthcare system.

1 reference

https://api.crossref.org/works/10.1111%2FDOM.12173

21 January 2018

Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data

1 reference

https://api.crossref.org/works/10.1111%2FDOM.12173

21 January 2018

Positive predictive value of ICD-9 codes 410 and 411 in the identification of cases of acute coronary syndromes in the Saskatchewan Hospital automated database

1 reference

https://api.crossref.org/works/10.1111%2FDOM.12173

21 January 2018

Part 10: Acute Coronary Syndromes: 2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care

1 reference

https://api.crossref.org/works/10.1111%2FDOM.12173

21 January 2018

Biased Selection of Controls for Case-Control Analyses of Cohort Studies

1 reference

https://api.crossref.org/works/10.1111%2FDOM.12173

21 January 2018

The risk of overall mortality in patients with type 2 diabetes receiving glipizide, glyburide, or glimepiride monotherapy: a retrospective analysis

1 reference

https://api.crossref.org/works/10.1111%2FDOM.12173

21 January 2018

A systematic review of adherence with medications for diabetes

1 reference

https://api.crossref.org/works/10.1111%2FDOM.12173

21 January 2018

Comorbidity measures for use with administrative data

1 reference

https://api.crossref.org/works/10.1111%2FDOM.12173

21 January 2018

Immeasurable time bias in observational studies of drug effects on mortality.

1 reference

https://api.crossref.org/works/10.1111%2FDOM.12173

21 January 2018

Comparison of two sulfonylureas with high and low myocardial K(ATP) channel affinity on myocardial infarct size and metabolism in a rat model of type 2 diabetes

1 reference

https://api.crossref.org/works/10.1111%2FDOM.12173

21 January 2018

Analysis of individual drug use as a time-varying determinant of exposure in prospective population-based cohort studies

1 reference

https://api.crossref.org/works/10.1111%2FDOM.12173

21 January 2018

Effects of gliclazide on platelet aggregation and the plasminogen activator inhibitor type 1 level in patients with type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1111%2FDOM.12173

21 January 2018

Blockers of the ATP-sensitive potassium channel SUR2A/Kir6.2: a new approach to prevent sudden cardiac death

1 reference

https://api.crossref.org/works/10.1111%2FDOM.12173

21 January 2018

Arrhythmias and mortality after myocardial infarction in diabetic patients. Relationship to diabetes treatment

1 reference

https://api.crossref.org/works/10.1111%2FDOM.12173

21 January 2018

No differences in mortality between users of pancreatic-specific and non-pancreatic-specific sulphonylureas: a cohort analysis

1 reference

https://api.crossref.org/works/10.1111%2FDOM.12173

21 January 2018

Glibenclamide-related excess in total and cardiovascular mortality risks: data from large Ukrainian observational cohort study

1 reference

https://api.crossref.org/works/10.1111%2FDOM.12173

21 January 2018

Sulfonylureas and prognosis after myocardial infarction in patients with diabetes: a population-based follow-up study.

1 reference

https://api.crossref.org/works/10.1111%2FDOM.12173

21 January 2018

Identifiers

10.1111/DOM.12173

1 reference

Europe PubMed Central

27 November 2017

1 reference

Europe PubMed Central

27 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43901204&oldid=2104260998"